TLR4 and metabolic dysfunction-associated steatotic liver disease: For example, acetate and propionate have been shown to reduce the hepatic gene and protein expression of lipogenic enzymes, thereby preventing liver steatosis [26,35], while butyrate attenuated the progression of MASLD by inhibiting Toll-like receptor 4 (Tlr4) mRNA and iNOS expression [36].